In English | En español
Questions About Cancer? 1-800-4-CANCER

Featured Clinical Trials

Highlighted NCI-Supported Cancer Studies < Back to Main

Page Options

  • Print This Page
  • Email This Document

Search Featured Trials

Prostate Cancer - Featured Clinical Trials

The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:

  • Comparing Radiation Therapies for Prostate Cancer
    (Posted: 06/26/2007) - In this trial, men with favorable-risk, localized prostate cancer will be randomly assigned to receive conventionally fractionated radiation therapy over the course of about eight weeks (41 daily treatments) or hypofractionated radiotherapy over a five-and-a-half week period (28 daily treatments).
  • Combination Therapy for High-Risk Prostate Cancer
    (Posted: 12/05/2006) - In this trial, after initial radiation and hormone therapy, men with localized, high-risk, androgen-responsive prostate cancer will be treated with the drugs docetaxel and prednisone.
  • Prostate Cancer Vaccine Trial
    (Posted: 10/03/2006) - In this clinical trial, researchers are testing a new type of vaccine therapy in patients with prostate cancer that has recurred locally or progressed following previous treatment.
  • Targeted Therapy for Metastatic Prostate Cancer
    (Posted: 06/20/2006) - This trial is evaluating the addition of two targeted therapies, bevacizumab and thalidomide, to chemotherapy with docetaxel and prednisone for patients with androgen-independent, metastatic prostate cancer.
  • MRI-Guided Radiotherapy for Prostate Cancer
    (Posted: 04/11/2006) - In this phase I trial, doctors will study the side effects and determine the best dose of a new treatment for localized prostate cancer called intensity-modulated external-beam radiation therapy.
< Previous  1 2 3 4 5  Next >